Lucintel Forecasts the Global Pain Patch Market to Reach $7.1 billion by 2030

Market-Research

 

https://www.lucintel.com/pain-patch-market.aspx

According to a market report by Lucintel, the future of the global pain patch market looks promising with opportunities in the online pharmacy, retail pharmacy, and hospital pharmacy markets. The global pain patch market is expected to reach an estimated $7.1 billion by 2030 with a CAGR of 4.8% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic pain and growing cases of sports and work related trauma injuries.

A more than 150 — page report is developed to understand Trends, opportunity and forecast in pain patch market to 2030 by type (opioid and non-opioid), route of administration (metered dose and microneedle patches), therapeutic use (pain relief, anesthesia, smoking cessation, cough suppression, and diarrhea suppression), distribution channel (online pharmacies, retail pharmacies, hospital pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

In this market, opioid and non-opioid are the major segments of pain patch market by type. Lucintel forecasts that non-opioid is expected to witness the higher growth over the forecast period due to its rising usage as an alternative of painkillers that can still effectively relieve symptoms without carrying the same risks.

Within this market, retail pharmacy will remain the largest segment due to its rising preference among people to obtain advice on prescription drugs and guidance on how to use them during treatment.

Download sample by clicking on pain patch market

North America will remain the largest region over the forecast period due to availability of robust healthcare infrastructure and existence of major players in the region.

Teva Pharmaceutical Industries, Sorrento Therapeutics, Purdue Pharma, Grunenthal, Johnson and Johnson, Endo International, NEXGEL Advanced Hydrogel Solutions, Amneal Pharmaceuticals, Viatris, and Hisamitsu Pharmaceutical are the major suppliers in the pain patch market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1–972–636–5056 or write us at helpdesk@lucintel.com

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
 Roy Almaguer
 Lucintel
 Dallas, Texas, USA
 Email: roy.almaguer@lucintel.com 
 Tel. +1 972.636.5056

Explore Our Latest Publications

Tube Type Arrester Market in Canada

Mutual Inductor Market in Canada

Player Tracking Market in Canada

Thin-Film Power Inductor Market in Canada

Trimmer Potentiometer Market in Canada

Tubular Gel Battery Market in Canada